[
  {
    "sentence": "The 10-year cumulative risk of contralateral breast cancer in TP53 carriers was significantly higher than that in non-carrier (17.9% vs 3.6%, hazard ratio (HR) = 7.0, 95% CI:3.3–14.9, P < 0.001) (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The 10-year cumulative risk of contralateral breast cancer in TP53 carriers was significantly higher than that in non-carrier (17.9% vs 3.6%, hazard ratio (HR) = 7.0, 95% CI:3.3–14.9, P < 0.001) (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The 10-year cumulative risk of contralateral breast cancer in TP53 carriers was significantly higher than that in non-carrier (17.9% vs 3.6%, hazard ratio (HR) = 7.0, 95% CI:3.3–14.9, P < 0.001) (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  }
]